Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 10

    1.

    Formation of endothelial lumens requires a coordinated PKCepsilon-, Src-, Pak- and Raf-kinase-dependent signaling cascade downstream of Cdc42 activation.

    Koh W, Sachidanandam K, Stratman AN, Sacharidou A, Mayo AM, Murphy EA, Cheresh DA, Davis GE.

    J Cell Sci. 2009 Jun 1;122(Pt 11):1812-22. Epub 2009 May 12.PMID: 19435802 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Glycemic control prevents microvascular remodeling and increased tone in type 2 diabetes: link to endothelin-1.

    Sachidanandam K, Hutchinson JR, Elgebaly MM, Mezzetti EM, Dorrance AM, Motamed K, Ergul A.

    Am J Physiol Regul Integr Comp Physiol. 2009 Apr;296(4):R952-9. Epub 2009 Jan 28.PMID: 19176890 [PubMed - indexed for MEDLINE]Related articles

    3.

    Differential effects of diet-induced dyslipidemia and hyperglycemia on mesenteric resistance artery structure and function in type 2 diabetes.

    Sachidanandam K, Hutchinson JR, Elgebaly MM, Mezzetti EM, Wang MH, Ergul A.

    J Pharmacol Exp Ther. 2009 Jan;328(1):123-30. Epub 2008 Oct 21.PMID: 18941121 [PubMed - indexed for MEDLINE]Related articles

    4.

    Effect of chronic and selective endothelin receptor antagonism on microvascular function in type 2 diabetes.

    Sachidanandam K, Elgebaly MM, Harris AK, Hutchinson JR, Mezzetti EM, Portik-Dobos V, Ergul A.

    Am J Physiol Heart Circ Physiol. 2008 Jun;294(6):H2743-9. Epub 2008 Apr 18.PMID: 18424628 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Effect of chronic endothelin receptor antagonism on cerebrovascular function in type 2 diabetes.

    Harris AK, Elgebaly MM, Li W, Sachidanandam K, Ergul A.

    Am J Physiol Regul Integr Comp Physiol. 2008 Apr;294(4):R1213-9. Epub 2008 Feb 20.PMID: 18287215 [PubMed - indexed for MEDLINE]Related articles

    6.

    Evidence for vasculoprotective effects of ETB receptors in resistance artery remodeling in diabetes.

    Sachidanandam K, Portik-Dobos V, Harris AK, Hutchinson JR, Muller E, Johnson MH, Ergul A.

    Diabetes. 2007 Nov;56(11):2753-8. Epub 2007 Aug 1.PMID: 17670915 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Differential effects of ET(A) and ET(B) receptor antagonism on oxidative stress in type 2 diabetes.

    Elgebaly MM, Portik-Dobos V, Sachidanandam K, Rychly D, Malcom D, Johnson MH, Ergul A.

    Vascul Pharmacol. 2007 Aug-Sep;47(2-3):125-30. Epub 2007 Jun 6.PMID: 17597010 [PubMed - indexed for MEDLINE]Related articles

    8.

    Microvascular versus macrovascular dysfunction in type 2 diabetes: differences in contractile responses to endothelin-1.

    Sachidanandam K, Harris A, Hutchinson J, Ergul A.

    Exp Biol Med (Maywood). 2006 Jun;231(6):1016-21.PMID: 16741041 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Type 2 diabetes causes remodeling of cerebrovasculature via differential regulation of matrix metalloproteinases and collagen synthesis: role of endothelin-1.

    Harris AK, Hutchinson JR, Sachidanandam K, Johnson MH, Dorrance AM, Stepp DW, Fagan SC, Ergul A.

    Diabetes. 2005 Sep;54(9):2638-44.PMID: 16123352 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Oxidative stress and cardiovascular disease: antioxidants and unresolved issues.

    Sachidanandam K, Fagan SC, Ergul A.

    Cardiovasc Drug Rev. 2005 Summer;23(2):115-32. Review.PMID: 16007229 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...